Eupraxia Pharmaceuticals Inc. (EPRX.TO)
Develops drug delivery technology to treat osteoarthritis, esophageal inflammation, and other conditions.
8.56+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+16.9%
The outlook
EPRX.TO is trading near its 52-week lows, well below both its 50- and 200-day moving averages. Analyst consensus is strongly bullish with an average price target about 91% above current levels, though only three analysts cover the stock. Overall sentiment sits neutral despite the bullish analyst view, suggesting mixed market conviction.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 3 analysts
Price trendBelow its 50- & 200-day averages
52-week range27% of the way from its 52-week low to high
Price targetAvg target +91% vs current price
Analyst price target
~12-month · 3 analysts16.33average target+90.8% vs now
Now 8.56
Low 14.00High 18.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$559.2M
52-wk high
12.86
52-wk low
6.94
50-day avg
9.13
200-day avg
9.73
Trailing P/E
—